Ansari Nabiha Midhat, Khalid Usman, Markov Daniel, Bechev Kristian, Aleksiev Vladimir, Markov Galabin, Poryazova Elena
Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Department of General and Clinical Pathology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Cancers (Basel). 2025 May 28;17(11):1810. doi: 10.3390/cancers17111810.
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with diagnostic accuracy and early detection being critical to patient outcomes. Recent advances in artificial intelligence (AI) offer new opportunities to enhance diagnostic precision and clinical decision-making.
This literature review aims to explore recent developments in AI-augmented diagnostic approaches for EC, with a focus on applications in histopathology, imaging, and multi-omics, and to assess their clinical impact and future potential.
A non-systematic literature review was conducted to examine recent advances in artificial intelligence applications for the diagnosis of EC. Relevant studies were identified through searches on PubMed and Google Scholar, focusing on the integration of AI techniques in histopathology, imaging, and multi-omics data.
AI-driven diagnostic tools have shown high performance in detecting and characterizing EC across multiple modalities, often matching or exceeding expert-level accuracy. These technologies hold promise for earlier detection, better risk assessment, and more personalized treatment planning. However, further research and validation are needed to address current limitations and support their broader integration into clinical workflows.
子宫内膜癌(EC)是发达国家最常见的妇科恶性肿瘤,诊断准确性和早期检测对患者预后至关重要。人工智能(AI)的最新进展为提高诊断精度和临床决策提供了新机遇。
本综述旨在探讨人工智能增强的子宫内膜癌诊断方法的最新进展,重点关注其在组织病理学、影像学和多组学中的应用,并评估其临床影响和未来潜力。
进行了一项非系统性文献综述,以研究人工智能在子宫内膜癌诊断应用方面的最新进展。通过在PubMed和谷歌学术上搜索确定相关研究,重点关注人工智能技术在组织病理学、影像学和多组学数据中的整合。
人工智能驱动的诊断工具在多种模式下检测和表征子宫内膜癌方面表现出高性能,通常达到或超过专家级准确性。这些技术有望实现更早检测、更好的风险评估和更个性化的治疗规划。然而,需要进一步研究和验证以解决当前局限性,并支持它们更广泛地融入临床工作流程。